Marie Jachiet
Marie Jachiet is an expert in Dermatology at Hôpital Saint-Louis (France). As of October 2026, ScienceLeadR ranks Marie Jachiet in the top 1% of experts worldwide for Dermatitis. Marie Jachiet has authored 291 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 4 of them ongoing. SLR score: 833 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Immunology - Hematology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2012 - 2026
Number : 291
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Evidence-based guidelines for the diagnosis and management of adult-onset IgA vasculitis. PMID 42625065 — vasculitis, iga vasculitis, kidney, rheumatic diseases, diagnosis, therapeutics, prognosis | Nat Rev Rheumatol Top journal | 2026 | 0 |
| The spectrum of eosinophilic cellulitis (Wells' syndrome): new insights based on 114 cases. PMID 42551694 — hypersensitivity, adrenal cortex hormones, cellulitis, eosinophils, therapeutics | J Allergy Clin Immunol Pract | 2026 | 0 |
| Rapid efficacy of anifrolumab in refractory cutaneous dermatomyositis. PMID 42447155 — dermatomyositis, sexually transmitted diseases, skin diseases, connective tissue diseases, myositis | J Eur Acad Dermatol Venereol | 2026 | 0 |
| Recurrent Facial Folliculitis Caused by Klebsiella aerogenes Sequence Type 117 in Men who Have Sex with Men. PMID 42366116 — sexually transmitted diseases, communicable disease control, enterobacter aerogenes, sex, klebsiella, folliculitis, bacteria | Emerg Infect Dis | 2026 | 0 |
| Successful use of thalidomide in treating metastatic Crohn's disease. PMID 42229008 — sexually transmitted diseases, crohn disease, thalidomide, dermatology | Ann Dermatol Venereol | 2026 | 0 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate to Severe Atopic Dermatitis 2023-508235-31-00 — safety, dermatitis, signs and symptoms, adolescent, therapeutics, dermatitis, atopic | Phase 3 | Active not recruiting | 2024 |
| A Study to Assess the Long Term Efficacy and Safety of Afimkibart (RO7790121) in Patients with Atopic Dermatitis who participated in previous Afimkibart Clinical Trials 2025-520771-59-00 — safety, dermatitis, dermatitis, atopic | Phase 2 | Not yet recruiting | 2026 |
| Platform study to evaluate the efficacy and safety of investigational compound(s) in patients with moderate to severe atopic dermatitis 2024-519081-49-00 — safety, dermatitis, respect, dermatitis, atopic | Phase 2 | Recruiting | 2025 |
| Dupilumab step down strategy to maintain remission in adult and adolescents patients with atopic dermatitis a non inferiority randomized trial 2022-501179-23-00 — dermatitis, adolescent, dermatitis, atopic | Phase 4 | Active not recruiting | 2023 |
LeadR Networks
Main global connection map